The dose of total body irradiation (TBI), and GvHD prophilaxis have a crucial role on relapse risk and survival after BMT for leukaemia

Bone Marrow Transplant. 1991:7 Suppl 2:130.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Bone Marrow Transplantation / methods*
  • Bone Marrow Transplantation / mortality
  • Cyclophosphamide / therapeutic use
  • Cyclosporins / administration & dosage
  • Cyclosporins / therapeutic use
  • Graft vs Host Disease / mortality
  • Graft vs Host Disease / prevention & control*
  • Humans
  • Italy / epidemiology
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / mortality
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / surgery*
  • Leukemia, Myeloid, Acute / mortality
  • Leukemia, Myeloid, Acute / surgery*
  • Methotrexate / therapeutic use
  • Neoplasm Recurrence, Local / epidemiology
  • Prospective Studies
  • Radiotherapy Dosage
  • Risk Factors
  • Survival Rate
  • Whole-Body Irradiation* / mortality

Substances

  • Cyclosporins
  • Cyclophosphamide
  • Methotrexate